Does TORIPALIMAB Cause Off label use? 276 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 276 reports of Off label use have been filed in association with TORIPALIMAB (LOQTORZI). This represents 20.5% of all adverse event reports for TORIPALIMAB.
276
Reports of Off label use with TORIPALIMAB
20.5%
of all TORIPALIMAB reports
29
Deaths
137
Hospitalizations
How Dangerous Is Off label use From TORIPALIMAB?
Of the 276 reports, 29 (10.5%) resulted in death, 137 (49.6%) required hospitalization, and 41 (14.9%) were considered life-threatening.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TORIPALIMAB. However, 276 reports have been filed with the FAERS database.
What Other Side Effects Does TORIPALIMAB Cause?
Myelosuppression (590)
White blood cell count decreased (144)
Anaemia (67)
Hypothyroidism (67)
Neutrophil count decreased (67)
Nausea (60)
Rash (59)
Vomiting (58)
Platelet count decreased (53)
Diarrhoea (50)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which TORIPALIMAB Alternatives Have Lower Off label use Risk?
TORIPALIMAB vs TORSEMIDE
TORIPALIMAB vs TOVIAZ
TORIPALIMAB vs TOVORAFENIB
TORIPALIMAB vs TOZINAMERAN
TORIPALIMAB vs TRABECTEDIN